| Literature DB >> 29472910 |
Daniel Castillo1, Diliana Pérez-Reytor2, Nicolás Plaza2, Sebastián Ramírez-Araya2,3, Carlos J Blondel2, Gino Corsini2, Roberto Bastías4, David E Loyola5, Víctor Jaña6, Leonardo Pavez6,7, Katherine García2.
Abstract
Vibrio parahaemolyticus is the leading cause of seafood-borne gastroenteritis worldwide. As reported in other countries, after the rise and fall of the pandemic strain in Chile, other post-pandemic strains have been associated with clinical cases, including strains lacking the major toxins TDH and TRH. Since the presence or absence of tdh and trh genes has been used for diagnostic purposes and as a proxy of the virulence of V. parahaemolyticus isolates, the understanding of virulence in V. parahaemolyticus strains lacking toxins is essential to detect these strains present in water and marine products to avoid possible food-borne infection. In this study, we characterized the genome of four environmental and two clinical non-toxigenic strains (tdh-, trh-, and T3SS2-). Using whole-genome sequencing, phylogenetic, and comparative genome analysis, we identified the core and pan-genome of V. parahaemolyticus of strains of southern Chile. The phylogenetic tree based on the core genome showed low genetic diversity but the analysis of the pan-genome revealed that all strains harbored genomic islands carrying diverse virulence and fitness factors or prophage-like elements that encode toxins like Zot and RTX. Interestingly, the three strains carrying Zot-like toxin have a different sequence, although the alignment showed some conserved areas with the zot sequence found in V. cholerae. In addition, we identified an unexpected diversity in the genetic architecture of the T3SS1 gene cluster and the presence of the T3SS2 gene cluster in a non-pandemic environmental strain. Our study sheds light on the diversity of V. parahaemolyticus strains from the southern Pacific which increases our current knowledge regarding the global diversity of this organism.Entities:
Keywords: RTX; Vibrio parahaemolyticus; Zot; accessory genome; genomic island; non-toxigenic; prophage; virulence
Year: 2018 PMID: 29472910 PMCID: PMC5809470 DOI: 10.3389/fmicb.2018.00161
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Origin of V. parahaemolyticus strains whose DNA sequences were included in this study.
| Strain | Origin | Year | Sequencing status | N° contigs | Coverage | N50 | Accession number |
|---|---|---|---|---|---|---|---|
| VpKXa | Osaka, Japón | 1996 | Complete | 2 | Complete | 3,288,5888 | BA000031.2/BA000032.2 |
| PMC53.7 | Puerto Montt, Chile | 2007 | Draft | 27 | 100x | 543,576 | MKQF00000000 |
| PMC54.13 | Puerto Montt, Chile | 2013 | Draft | 28 | 113x | 509,179 | MKQX00000000 |
| PMA14.14 | Puerto Montt, Chile | 2014 | Draft | 30 | 100x | 521,587 | MKRA00000000 |
| PMA1.15 | Puerto Montt, Chile | 2015 | Draft | 130 | 65x | 77,968 | MKQV00000000 |
| PMA2.15 | Puerto Montt, Chile | 2015 | Draft | 209 | 60x | 42,215 | MKQT00000000 |
| PMA3.15 | Puerto Montt, Chile | 2015 | Draft | 80 | 71x | 137,938 | MKQU00000000 |
Strain characterization and classification according to mPCR and DGREA.
| Strain | mPCR | DGREA (Group) | ||
|---|---|---|---|---|
| VpKX | - | + | + | Pandemic (KX) |
| PMC 53.7 | - | - | + | Non-pandemic (1.5) |
| PMC 54.13 | - | - | + | Non-pandemic (54.13, this study) |
| PMA 14.14 | - | - | + | Non-pandemic (54.13, this study) |
| PMA 1.15 | - | - | + | Non-pandemic (1.15, this study) |
| PMA 2.15 | - | - | + | Non-pandemic (2.15, this study) |
| PMA 3.15 | - | - | + | Non-pandemic (3.15, this study) |
Genomic overview of the V. parahaemolyticus strains analyzed in this study.
| Strain | Size (Mbp) | Total genes | Total CDS | %G+C | rRNA | tRNA |
|---|---|---|---|---|---|---|
| VpKX | 5.16 | 4,991 | 4,831 | 45.4 | 34 | 116 |
| PMC 53.7 | 5.09 | 4,649 | 4,476 | 45.3 | 28 | 98 |
| PMC 54.13 | 5.13 | 4,646 | 4,431 | 45.3 | 21 | 103 |
| PMA 14.14 | 5.17 | 4,755 | 4,586 | 45.1 | 25 | 98 |
| PMA 1.15 | 5.23 | 4,843 | 4,275 | 45.2 | 21 | 75 |
| PMA 2.15 | 4.96 | 4,556 | 4,151 | 45.4 | 6 | 64 |
| PMA 3.15 | 5.03 | 4,585 | 4,316 | 45.3 | 4 | 87 |
Features of the 15 strain-specific genomic islands in the V. parahaemolyticus genomes.
| Strain | GI Numbera | Contig (position) | Analogous position in VpKX (locus tag)b | Length (bp) | ORFs | G + C% | Presence of integrase or transposase | Main feature genes |
|---|---|---|---|---|---|---|---|---|
| PMC 53.7 | 1 | 1 (681,315–745,872) | VPA1158–VPA1159 | 64,558 | 47 | 45.1 | Yes | Phospholipases; antibiotic resistance; enterotoxin |
| PMC 53.7 | 2 | 1 (1,128,115–1,156,441) | VPA0797–VPA0798 | 28,327 | 33 | 40.2 | No | Ornithine and sperdimine metabolism |
| PMC 53.7 | 3 | 1 (178,424–189,151) | VPA1709–VPA1711 | 10,728 | 10 | 48.7 | No | Glucuronate and mannonate metabolism |
| PMC 53.7 | 4 | 12 (26,197–35,415) | VPA3056–VPA3057 | 9,219 | 13 | 40.1 | No | Unknown |
| PMA 1.15 | 5 | 64 (1,686–25,920) | VP2101–VPt050 | 24,235 | 29 | 43.0 | Yes | DNAse; RTX toxin |
| PMA 1.15 | 6 | 36 (12,379–27,949) | VP0079–VP0080 | 15,571 | 11 | 41.0 | Yes | Type I restriction/modification system |
| PMA 1.15 | 7 | 33 (39,633–50,149) | VPA0113–VPA0114 | 10,487 | 5 | 40.8 | Yes | Unknown |
| PMA 1.15 | 8 | 93 (228–10,400) | ND | 10,137 | 11 | 41.1 | No | LPS modification; metabolism |
| PMA 2.15 | 9 | 37 (1–8,835) | ND | 8,835 | 8 | 39.2 | Yes | LPS modification |
| PMA 2.15 | 10 | 4 (103,120–110,414) | VPA0992–VPA0993 | 8,295 | 7 | 40.1 | No | CRISPR-associated proteins |
| PMA 2.15 | 11 | 1 (70,850–85,817) | VPAt07–VPA0603 | 14,968 | 11 | 38.5 | No | dGTPases |
| PMA 3.15 | 12 | 15 (180,249–193,928) | VPA1167–VPA1168 | 13,680 | 17 | 38.6 | Yes | LPS modification |
| PMA 3.15 | 13 | 5 (128,991–137,648) | VPA0391–VPA0392 | 8,658 | 8 | 44.4 | No | Transporters; two-component system |
| PMC 54.13 | 14 | 10 (20,491–27,744) | VP1762–VP1763 | 8,254 | 8 | 42.1 | No | Hemolysin |
| PMA 14.14 | 15 | 9 (1–170,892) | ND | 170,892 | 175 | 39.6 | Yes | DNA metabolism; unknown |
Unique prophage-related sequences distributed in V. parahaemolyticus strains.
| Prophage | Strain | Size (bp) | #ORFs | %CG | Contig (position bp) | Status |
|---|---|---|---|---|---|---|
| 1 | PMC 53.7 | 11,378 | 13 | 43.2 | 6 (179,070–190,447) | Incomplete |
| 2 | PMA 1.15 | 33,500 | 48 | 46.1 | 9 (64,331–97,830) | Complete |
| 3 | PMA 1.15 | 26,568 | 44 | 45.8 | 121 (1–26568) | Complete |
| 4 | PMA 2.15 | 8,380 | 10 | 45.3 | 2 (6,375–14,754) | Incomplete |
| 5 | PMA 3.15 | 10,187 | 11 | 45.1 | 9 (80,993–91,179) | Incomplete |